Thermo Fisher Scientific | TMO - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Abbott USD 18.38B 1.88B 2026-03
Agilent USD 2.29B 20M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Bio Techne USD 163.7M 10.42M 2026-06
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
Boston Scientific USD 5.98B 446M 2026-09
Bruker USD 1.2B 150.4M 2026-06
Charles River Laboratories USD 1.13B 41.04M 2026-06
Danaher USD 9.05B 945M 2026-09
Dentsply International USD 1.18B 22M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
General Electric Aerospace USD 42.4B 1.96B 2026-09
Henry Schein USD 3.49B 191M 2026-06
Illumina USD 1.16B 422M 2026-09
Intuitive Surgical USD 3.23B 652.4M 2026-09
IQVIA Holdings USD 7.78B 1.04B 2026-09
Laboratory Of America USD 2.82B 695M 2026-09
Medtronic USD 11.8B 141M 2026-06
Mettler Toledo International USD 1.2B 92.14M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Olympus JPY 467.38B 30.5B 2026-06
OraSure Technologies USD 25.12M 18.96M 2026-06
Quest Diagnostics USD 1.83B 46M 2026-09
Repligen USD 125.69M 6.97M 2026-09
Revvity USD 1.28B 37.71M 2026-06
Stryker USD 6.5B 184M 2026-09
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Veracyte USD 62.74M 6.62M 2026-06
Waters USD 2.27B 1.03B 2026-03
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06